Crispr Therapeutics shares owned by Quadcap Wealth Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Quadcap Wealth Management
from 13F filings
Historical chart of Quadcap Wealth Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Quadcap Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Quadcap Wealth Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $588k | 9.4k | 62.60 |